Researchers discover new genetic mutation that causes male infertility
Researchers at Ben-Gurion University of the Negev and Soroka University Medical Center in Beer-Sheva, Israel have discovered a new genetic mutation that prevents sperm production.
TBIT, pixabay.com, CC0
Five percent of men suffer from infertility and approximately one percent suffer from azoospermia, which is a condition in which sperm cells are completely absent.
For the first time, the researchers identified a mutation in the gene TDRD9 using whole genome genotyping and sequencing. The results were published in the Journal of Medical Genetics.
The findings were possible only because five men from a single Bedouin family suffered from lack of sperm and spermatogenic arrest in their testis with no obvious cause. The men were being treated by Dr. Eitan Lunenfeld and his team at the Soroka University Medical Center In Vitro Fertilization Unit.
Profs. Ruti Parvari and Mahmoud Huleihel of the Shraga Segal Department of Microbiology, Immunology and Genetics discovered the mutation in the gene, which normally protects the full DNA sequence in sperm. This mutation inactivates the function of the gene and arrests sperm production.
"With the link between this damaged gene and male infertility now identified, specific scans will be available to test for the mutation which will be important for treatment of a couple's infertility," the researchers say.
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Researchers describe for first time how some bacteria kill males: They first invade the mother
Genomics for biodiversity conservation - Genomic analyses provide important insights for conservation management
Trimeresurus_mucrosquamatus
Building a better botox - Small engineering tweaks to botulinum toxin B could make it more effective and longer-lasting with fewer side effects
A new Concept in Microscopy: Self-reconstructing Laser Beams - Researchers at the University of Freiburg are developing a microscope with illuminating beams that actively refocus in a light-scattering medium
Innogenetics completes first US clinical trial on time - Safety and tolerability results of hepatitis B therapeutic vaccine phase I study
Laboratory of the future at analytica in Munich in the present
Bulk solids industry cautiously optimistic for 2023 - Manufacturers in the ventilation and process technology sectors are cautiously optimistic about the future after surviving the Corona crisis
